Biomarkers Market: Global Market Size, Trends, Competitive, Historical & Forecast Analysis, 2019-2025

Report ID: BMRC 408 | Number of pages: 205 | Publish Date: Jul 2019 | Publisher: BMRC | Category: Lifesciences and Healthcare
Our final report will cover impact analysis of COVID-19 outbreak
New
Biomarkers Market was valued at USD 36.3 Billion in 2018 and expected to reach USD 91.4 Billion by 2025 with a CAGR of 14.1% during the forecast period. Increasing prevalence of cancer and growing precision medicine market are amongst the pivotal factors anticipated to spur the growth of Biomarkers Market.

Scope of Biomarkers Market Report:

The global biomarkers market is witnessing a healthy growth trajectory attributed to the growing application of biomarkers in diagnostics, increasing funding for biomarkers research, as well as its rising usage in drug discovery. Biomarkers are biological molecules found in body fluids and tissues that help in crucial clinical decision making and diagnosing various health conditions of the patients. Since the molecules can analyze pharmacological responses and pathological indications, they can effectively assist in process of drug discovery and development. The diagnostics industry has been witnessing a shift in trend from using conventional diagnostic tools towards using more advanced diagnostic methods that focus on producing accurate and consistent results during early stage of diseases. This has led to boost in demand for biomarkers which are minimally or non-invasive tools to detect diseases such as cancer at early stage. Moreover, growing usage of precision medicine should further boost the biomarkers market growth. Apart from this, expediting growth in the healthcare IT industry and low costs of clinical trials in emerging countries has favored the entry of various new players in the market. A large chunk of funding is being invested in research and development for new product launches. For instance, in March 2018, Genomic Health, Inc. launched the Oncotype DX AR-V7 Nucleus Detect test. The AR-V7 protein is a prognostic and predictive biomarker. This test aids physicians in taking therapeutic decisions in patients suffering from metastatic castration-resistant prostate cancer (mCRPC) by accurately detecting a splice variant of the androgen receptor protein (AR-V7) in the nucleus of circulating tumor cells (CTCs). Recent Developments In May 2019, Qiagen announced the immediate launch of its first companion diagnostics assay therascreen PIK3CA RGQ PCR Kit (therascreen PIK3CA Kit) post U.S. FDA regulatory approval as a companion diagnostic to assist in diagnosing breast cancer patients that would be eligible for treatment with newly approved therapy PIQRAY (alpelisib) developed and marketed by Novartis. Key Players in Biomarkers Market Some of the major players operating in the Global Biomarkers Market include Siemens Healthineers, Medtronic, F. Hoffman LA Roche Ltd., Abbott Laboratories Nexus-DX, Qiagen N.V., PerkinElmer, Inc., Lifesign LLC., Merck & Co, Inc., Bio-Rad Laboratories, EKF Diagnostics Holdings plc, Singulex, Inc., Signosis, Inc, and BioSims Technologies among others. Global Biomarkers market is segmented on the basis of product, type, application, and disease indication. The Global Biomarkers Market by product includes consumables, services, and software, while based on type the industry is segmented into safety, efficacy, and validation. By application market segmentation includes diagnostics, drug development, personalized medicine, and disease risk assessment. Biomarkers market by disease indication comprises of cancer, cardiovascular diseases, neurological diseases, immunological diseases, and others. Increasing incidence of cancer and growing precision medicine market are some of the pivotal factors boosting the Biomarkers market growth. Increasing incidence of cancer is one of the pivotal factors which is set to drive the growth of Biomarkers Market. According to World Health Organization (WHO) statistics, various types of cancer accounted for more than 9.5 million deaths in 2018 worldwide. Cancer biomarkers are released by cancer causing tumors that can be detected in blood stream and other tissues, thus helping in early clinical evaluation and deciding the course of treatment. Moreover, the World Health Assembly has passed the resolution in 2017 for Cancer Prevention and Control. This integrated approach (WHA70.12) has recommended the governments and WHO to speed up action plans specified in the Global Action Plan and 2030 UN Agenda for Sustainable Development to reduce premature mortality from cancer. This has led to a boost in demand for early cancer screening tests and procedures. Increasing focus of research institutes to develop such biomarkers is likely to spur the global Biomarkers Market growth. Geographically, this report split global into several key Regions, revenue (Million USD) The geography (North America, Europe, Asia-Pacific, Latin America and Middle East & Africa) focusing on key countries in each region. It also covers market drivers, restraints, opportunities, challenges, and key issues in Global Biomarkers Market. Key Benefits for Biomarkers Market Reports • Global market report covers in-depth historical and forecast analysis. • Global market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market Opportunities, Competitive Analysis, Regional and Country Level. • Global market report helps to identify opportunities in market place. • Global market report covers extensive analysis of emerging trends and competitive landscape.

Biomarkers Market Segmentation:-

By Product: • Consumables • Services • Software By Type: • Safety • Efficacy • Validation By Application: • Diagnostics • Drug Development • Personalized Medicine • Disease Risk Assessment By Disease Indication: • Cancer • Cardiovascular Diseases • Neurological Diseases • Immunological Diseases • Others By Region • North America o U.S. o Canada o Mexico • Europe o UK o France o Germany o Russia o Rest of Europe • Asia-Pacific o China o South Korea o India o Japan o Rest of Asia-Pacific • LAMEA o Latin America o Middle East o Africa North America grabbed the largest share in Biomarkers Market globally In 2018, North America accounted for the largest share in the global biomarkers market owing to increasing adoption of precision medicine and rising prevalence of cancer in the region. The largest share of the region is also attributed to the rise in number of cancer cases in the U.S. and launch of Precision Medicine Initiative (PMI) by the U.S. government in 2015. According to the National Cancer Institute statistics, more than 16.5 million cases of cancer were diagnosed in 2016 in the U.S, and this number is expected to reach to 19 million in 2024. The increasing application of biomarkers in the field of precision medicine should also drive the market in this region. Identification of biomarkers is essential for the development of precision medicine. The U.S. precision medicine industry has been booming post the launch of Precision Medicine Initiative by the government in 2015. The initiative aimed at improving the treatment outcome by offering tailor made therapies to patients. This has spurred the development of novel treatments and drugs based on an individual’s genetic profile and characteristics of tumor. The Asia Pacific Biomarkers market is set to showcase lucrative growth in the coming years due to vast patient pool, increasing awareness regarding early disease detection and rising healthcare expenditure in the emerging countries of India and China. Biomarkers Market Key Players: • Siemens Healthineers • Medtronic • F. Hoffman LA Roche Ltd. • Abbott Laboratories Nexus-DX • Qiagen N.V. • PerkinElmer, Inc. • Lifesign LLC. • Merck & Co, Inc. • Bio-Rad Laboratories • EKF Diagnostics Holdings plc • Others This comprehensive report will provide: • Enhance your strategic decision making • Assist with your research, presentations and business plans • Show which emerging market opportunities to focus on • Increase your industry knowledge • Keep you up-to-date with crucial market developments • Allow you to develop informed growth strategies • Build your technical insight • Illustrate trends to exploit • Strengthen your analysis of competitors • Provide risk analysis, helping you avoid the pitfalls other companies could make • Ultimately, help you to maximize profitability for your company. Our Market Research Solution Provides You Answer to Below Mentioned Question: • Which are the driving factors responsible for the growth of market? • Which are the roadblock factors of this market? • What are the new opportunities, by which market will grow in coming years? • What are the trends of this market? • Which are main factors responsible for new product launch? • How big is the global & regional market in terms of revenue, sales and production? • How far will the market grow in forecast period in terms of revenue, sales and production? • Which region is dominating the global market and what are the market shares of each region in the overall market in 2017? • How will each segment grow over the forecast period and how much revenue will these segment account for in 2025? • Which region has more opportunities?
Interested in this report?
Get your sample now!
Table of Content

1. Chapter - Report Methodology
1.1. Research Process 
1.2. Primary Research 
1.3. Secondary Research
1.4. Market Size Estimates
1.5. Data Triangulation
1.6. Forecast Model 
1.7. USP’s of Report 
1.8. Report Description 
2. Chapter – Global Biomarkers Market Overview: Qualitative Analysis
2.1. Market Introduction
2.2. Executive Summary 
2.3. Global Biomarkers Market Classification
2.4. Market Drivers
2.5. Market Restraints
2.6. Market Opportunity
2.7. Biomarkers Market: Trends
2.8. Porter’s Five Forces Analysis
2.8.1. Bargaining Power of Suppliers
2.8.2. Bargaining Power of Consumers
2.8.3. Threat of New Entrants
2.8.4. Threat of Substitute Product and Services
2.8.5. Competitive Rivalry within the Industry
2.9. Market Attractiveness Analysis 
2.9.1. Market Attractiveness Analysis by Segmentation 
2.9.2. Market Attractiveness Analysis by Region 
3. Chapter - Global Biomarkers Market Overview: Quantitative Analysis
3.1. Global Biomarkers Market Revenue (USD Million), Market Share (%) and Growth Rate (%), 2014- 2025
3.2. Global Biomarkers Market Revenue Market Share (%), 2014- 2025
3.3. Global Biomarkers Market Sales (Number of Units), Market Share (%) and Growth Rate (%), 2014- 2025
3.4. Global Biomarkers Market Sales Market Share (%), 2014- 2025
4. Chapter – Global Biomarkers Market Analysis: By Product
5. Chapter – Global Biomarkers Market Analysis: By Type
6. Chapter – Global Biomarkers Market Analysis: By Application
7. Chapter – Global Biomarkers Market Analysis: By Disease Indication
8. Chapter - Global Biomarkers Market Analysis: By Manufacturer 
8.1. Global Biomarkers Market Revenue (USD Million), by Manufacturer, 2014 - 2025
8.2. Global Biomarkers Market Share (%), by Manufacturer, 2018
8.3. Global Biomarkers Market Sales (Number of Units), by Manufacturer, 2014 - 2025
8.4. Global Biomarkers Market Share (%), by Manufacturer, 2018
8.5. Global Biomarkers Market Price (USD/Unit), by Manufacturer, 2014 - 2025
8.6. Global Biomarkers Market Revenue Growth Rate (%), by Manufacturer, 2014 – 2025
8.7. Merger & Acquisition
8.8. Collaborations and Partnership
8.9. New Product Launch
9. Chapter –Biomarkers Market: Regional Analysis
9.1. North America
9.1.1. North America Biomarkers Market Revenue (USD Million) and Growth Rate (%), 2014 – 2025.
9.1.2. North America Biomarkers Market Revenue (USD Million) By Country, 2014 – 2025.
9.1.3. North America Biomarkers Revenue Market Share (%) By Country, 2014 – 2025.
9.1.4. North America Biomarkers Market Revenue (USD Million) and Growth Rate, By Market Segmentation, 2014 – 2025.
9.1.5. North America Biomarkers Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2025.
9.1.6. North America Biomarkers Market Sales (Number of Units) and Growth Rate (%), 2014 – 2025.
9.1.7. North America Biomarkers Market Sales (Number of Units) By Country, 2014 – 2025.
9.1.8. North America Biomarkers Sales Market Share (%) By Country, 2014 – 2025.
9.1.9. North America Biomarkers Market Sales (Number of Units) and Growth Rate, By Market Segmentation, 2014 – 2025.
9.1.10. North America Biomarkers Market Sales (Number of Units), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2025.
9.2. Europe
9.3. Asia Pacific
9.4. Latin America
9.5. Middle East & Africa
10. Chapter - Company Profiles
10.1. Siemens Healthineers
10.1.1. Overview
10.1.2. Financials
10.1.3. Product portfolio
10.1.4. Biomarkers Market Revenue (USD Million) and Market Share (%), 2014 - 2018
10.1.5. Biomarkers Sales Market Share (%), 2014 - 2018
10.1.6. Business strategy
10.1.7. Recent developments
10.2. Medtronic
10.3. F. Hoffman LA Roche Ltd.
10.4. Abbott Laboratories Nexus-DX
10.5. Qiagen N.V.
10.6. PerkinElmer, Inc.
10.7. Lifesign LLC.
10.8. Merck & Co, Inc.
10.9. Bio-Rad Laboratories
10.10. EKF Diagnostics Holdings plc
10.11. Singulex, Inc.
10.12. Signosis, Inc
10.13. BioSims Technologies
10.14. Others
11. Chapter – Market Research and Findings


This free Sample Report is purely a representation of our full report, for evaluating the market scope/data and make informed purchase decisions.